Evidence map›Paper›PMID 28748640›Full record

ArticleClinical endocrinology2017

Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.

William Atiomo, Mohamad Nasir Shafiee, Caroline Chapman, Veronika M Metzler, Jad Abouzeid, Ayşe Latif, Amy Chadwick, Sarah Kitson, Vanitha N Sivalingam, Ian J Stratford and 8 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Clinical endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer.International journal of molecular sciences · 2020
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

William AtiomoFaculty of Medicine and Health Sciences, Division of Obstetrics and Gynaecology and Child Health, School of Medicine, Queen's Medical Centre, Nottingham University Hospital, Nottingham, UK.
Mohamad Nasir ShafieeFaculty of Medicine and Health Sciences, Division of Obstetrics and Gynaecology and Child Health, School of Medicine, Queen's Medical Centre, Nottingham University Hospital, Nottingham, UK.
Caroline ChapmanFaculty of Medicine and Health Sciences, Division of Obstetrics and Gynaecology and Child Health, School of Medicine, Queen's Medical Centre, Nottingham University Hospital, Nottingham, UK.
Veronika M MetzlerFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Jad AbouzeidFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Ayşe LatifFaculty of Biology, Medicine and Health, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK.
Amy ChadwickFaculty of Biology, Division of Molecular & Clinical Cancer Sciences, Medicine and Health, University of Manchester, Manchester, UK.
Sarah KitsonFaculty of Biology, Division of Molecular & Clinical Cancer Sciences, Medicine and Health, University of Manchester, Manchester, UK.
Vanitha N SivalingamFaculty of Biology, Division of Molecular & Clinical Cancer Sciences, Medicine and Health, University of Manchester, Manchester, UK.
Ian J StratfordFaculty of Biology, Medicine and Health, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK.
Catrin S RutlandFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Jenny L PerssonClinical Research Center, Lund University, Malmö, Sweden.
Niels ØdumDepartment of Immunology and Microbiology, University of Copenhagen, Kobenhavn, Denmark.
Pablo Fuentes-UtrillaEdinburgh Genomics, University of Edinburgh, Edinburgh, UK.
Jennie N JeyapalanFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
David M HeerySchool of Pharmacy, University of Nottingham, Nottingham, UK.
Emma J CrosbieFaculty of Biology, Division of Molecular & Clinical Cancer Sciences, Medicine and Health, University of Manchester, Manchester, UK.
Nigel P MonganFaculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.ORCID http://orcid.org/0000-0001-5438-1126
Manchester Academic Health Science Centre · GBUniversity of Nottingham · GBQueen's Medical Centre · GBEdinburgh Genomics · GBLund University · SEUniversity Kebangsaan Malaysia Medical Centre · MYUniversity of Copenhagen · DK

Funding

Cancer Research UK 16397Cancer Research UK 18294Department of Health NIHR-CS-012-009Medical Research Council G0500366Wellcome Trust
6 · The paper itself

Abstract

objectiveWomen with a prior history of polycystic ovary syndrome (PCOS) have an increased risk of endometrial cancer (EC).

aimTo investigate whether the endometrium of women with PCOS possesses gene expression changes similar to those found in EC. DESIGN AND

methodsPatients with EC, PCOS and control women unaffected by either PCOS or EC were recruited into a cross-sectional study at the Nottingham University Hospital, UK. For RNA sequencing, representative individual endometrial biopsies were obtained from women with EC, PCOS and a woman unaffected by PCOS or EC. Expression of a subset of differentially expressed genes identified by RNA sequencing, including NAD(P)H quinone dehydrogenase 1 (NQO1), was validated by quantitative reverse transcriptase PCR validation (n = 76) and in the cancer genome atlas UCEC (uterine corpus endometrioid carcinoma) RNA sequencing data set (n = 381). The expression of NQO1 was validated by immunohistochemistry in EC samples from a separate cohort (n = 91) comprised of consecutive patients who underwent hysterectomy at St Mary's Hospital, Manchester, between 2011 and 2013. A further 6 postmenopausal women with histologically normal endometrium who underwent hysterectomy for genital prolapse were also included. Informed consent and local ethics approval were obtained for the study.

resultsWe show for the first that NQO1 expression is significantly increased in the endometrium of women with PCOS and EC. Immunohistochemistry confirms significantly increased NQO1 protein expression in EC relative to nonmalignant endometrial tissue (P < .0001).

conclusionsThe results obtained here support a previously unrecognized molecular link between PCOS and EC involving NQO1.

Indexed as

AdultAgedAged, 80 and overCase-Control StudiesCross-Sectional StudiesEndometrial NeoplasmsEndometriumFemaleGene ExpressionHumansImmunohistochemistryMiddle AgedNAD(P)H Dehydrogenase (Quinone)Polycystic Ovary SyndromeYoung AdultNAD(P)H Dehydrogenase (Quinone)NQO1 protein, humanendometrial cancerendometriumNQO1polycystic ovary syndrome

Identifiers

PMID28748640
PMCPMC5697576
OpenAlexW2739525201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.